以岭药业：盐酸伐昔洛韦片取得药品注册证书

Core Viewpoint - Yiling Pharmaceutical's subsidiary, Yiling Wanzhou International Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing authorization application of Valaciclovir Hydrochloride Tablets, obtaining the drug registration certificate [1] Group 1 - Yiling Pharmaceutical's full ownership of Yiling Wanzhou International Pharmaceutical Co., Ltd. is confirmed [1] - The approved drug, Valaciclovir Hydrochloride Tablets, is a significant addition to the company's product portfolio [1] - The approval from the National Medical Products Administration marks a key milestone for the company in expanding its market presence [1]